The stock of SomaLogic Inc. (NASDAQ:SLGC) increased by $0.11 on Tuesday to $2.14, up 5.42 percent. The last five days have seen an average of 1,155,645 shares of common stock traded. 9 times new highs were reached in the current year, with a fall of -$0.25. The average number of shares traded over the last 20 days was 910,406, while the average volume over the last 50 days totaled 1,058,753.
SLGC stock dropped -9.32% since last month. On 08/14/23, the company’s shares reached a one-month low of $1.99. The stock touched a high of $4.46 on 02/02/23, after rallying from a low of $1.98 in 52 weeks. The price of SLGC stock has declined by -14.74% or -$0.25 this year, reaching a new high 9 times. Still, the stock price is down -52.02% from the 52-week high.
Valuation Metrics
Beta for the stock is 1.70. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 4.17, the price-to-book (PB) ratio of 0.75.
Financial Health
For the three months ended June 29, SomaLogic Inc.’s quick ratio was 13.70, while its current ratio was 14.10, indicating its ability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 53.70% percent. Based on annual data, it had gross profit of $54.3 million and revenue of $97.67 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. SLGC’s return on assets (ROA) during the last 12 months has been -21.20%. There was a -31.10% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -24.20%.
Earnings Surprise
According to SomaLogic Inc.’s quarterly financial report for the quarter that ended June 29, it had $62.06 million in cash and short-term investments. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $20.38 million, while revenues fell by -12.76% to $18.83 million. It was predicted that SomaLogic Inc.’s quarterly earnings would be -$0.13, but it ended up being -$0.15, beating the consensus by 13.30%. EBITDA was -$38.93 million for the quarter. At the end of SomaLogic Inc.’s most recent quarter ended June 29, its liabilities totaled 78.93 million, while its total debt was $3.93 million. Equity owned by shareholders amounts to $187.94 million.
Technical Picture
Here’s a quick look at SomaLogic Inc.’s (SLGC) price momentum from a technical perspective. As of 14 August, the RSI 9-day stood at 55.52%, suggesting the stock is Neutral, with a 65.23% historical volatility rate.
The stochastic %K and %D were 26.15% and 13.72% respectively, while the average true range (ATR) was 0.15. Based on the 14-day stochastic reading of 55.21%, the RSI (14) reading is 51.01%. On the 9-day MACD Oscillator, the stock is at -0.01, and the 14-day reading is at -0.07.
Analyst Ratings
In its analyst report released on February 01, 2022, Stifel began covering SomaLogic Inc. (NASDAQ: SLGC). The stock was rated as a Buy by the brokerage firm. Analysts have assigned SomaLogic Inc. (SLGC) an Buy rating. SLGC is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 4 others recommend it as a buy.
What is SLGC’s price target for the next 12 months?
The current consensus forecast for the stock is between $3.50 and $7.00, with a median target price of $6.00. In analyzing these forecasts, the average price target given by analysts for SomaLogic Inc. (SLGC) is $5.63.
